{"id":1922,"date":"2021-01-25T00:00:00","date_gmt":"2021-01-24T23:00:00","guid":{"rendered":"http:\/\/idlbiotech.com\/?p=1922"},"modified":"2021-05-26T09:01:55","modified_gmt":"2021-05-26T07:01:55","slug":"idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/","title":{"rendered":"IDL Biotech inkluderar ytterligare kliniker i sin p\u00e5g\u00e5ende multicenterstudie f\u00f6r UBC\u00ae Rapid i Sverige."},"content":{"rendered":"<p>IDL Biotech har f\u00f6r n\u00e4rvarande ett antal p\u00e5g\u00e5ende kliniska studier b\u00e5de internationellt och i Sverige, med syftet att p\u00e5visa den kliniska nyttan av UBC\u00ae Rapid vid bl\u00e5scancer och att testet ska inkluderas som ett komplement i uppf\u00f6ljningen av patienter med bl\u00e5scancer som klassificeras som h\u00f6griskpatienter.<\/p>\n<p><span>UBC\u00ae Rapid kan vara ett v\u00e4rdefullt komplement till dagens diagnostik. Den svenska multicenterstudien som genomf\u00f6rts p\u00e5 ett antal urologkliniker i Sverige \u00e4r en fas 2-studie d\u00e4r ett antal pilotstudier g\u00f6rs p\u00e5 patienter med nyuppt\u00e4ckt h\u00f6ggradig bl\u00e5scancer, patienter som haft \u00e5terfall och patienter med mer avancerad urotelial cancer under behandling eller uppf\u00f6ljning.<\/span><\/p>\n<p><span>\"P\u00e5 grund av Covid-19 f\u00f6rsenades flera av v\u00e5ra p\u00e5g\u00e5ende studier b\u00e5de internationellt och i Sverige under 2020. Efter jul har vi dock sett att en del av studierna l\u00e5ngsamt kommit ig\u00e5ng igen och genom att nu engagera ytterligare 3 kliniker f\u00f6r den svenska studien hoppas vi kunna inkludera patienter snabbare, s\u00e4ger Ann-Christine Nilsson, CSO och klinisk chef p\u00e5 IDL Biotech.\".&nbsp;<\/span><\/p>\n<p>L\u00e4s pressmeddelandet<strong><span> <a href=\"https:\/\/news.cision.com\/se\/idl-biotech\/r\/idl-biotech-inkluderar-ytterligare-kliniker-i-sin-pagaende-multicenterstudie-for-ubc--rapid-i-sverig,c3273245\">h\u00e4r<\/a><\/span><\/strong>Svenska<\/p>","protected":false},"excerpt":{"rendered":"<p>IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC\u00ae Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk. UBC\u00ae Rapid can be [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":2618,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[37],"tags":[],"dipi_cpt_category":[],"class_list":["post-1922","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bladder-cancer-health-information"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden. - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden. - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC\u00ae Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk. UBC\u00ae Rapid can be [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-24T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-26T07:01:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2183web.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"945\" \/>\n\t<meta property=\"og:image:height\" content=\"629\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"marie\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"marie\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/\"},\"author\":{\"name\":\"marie\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\"},\"headline\":\"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden.\",\"datePublished\":\"2021-01-24T23:00:00+00:00\",\"dateModified\":\"2021-05-26T07:01:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/\"},\"wordCount\":193,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2183web.jpg\",\"articleSection\":[\"Bladder cancer\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/\",\"name\":\"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden. - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2183web.jpg\",\"datePublished\":\"2021-01-24T23:00:00+00:00\",\"dateModified\":\"2021-05-26T07:01:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2183web.jpg\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/IDL_2183web.jpg\",\"width\":945,\"height\":629},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2021\\\/01\\\/25\\\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/69060a052e2a36c16244e75262d43000\",\"name\":\"marie\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g\",\"caption\":\"marie\"},\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/marie\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden. - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/","og_locale":"sv_SE","og_type":"article","og_title":"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden. - IDL Diagnostics","og_description":"IDL Biotech currently has a number of ongoing clinical studies both internationally and in Sweden, with the aim of demonstrating the clinical benefit of UBC\u00ae Rapid in bladder cancer and having the test included as a complement in the follow-up of patients with bladder cancer who are classified as high risk. UBC\u00ae Rapid can be [&hellip;]","og_url":"https:\/\/idldiagnostics.com\/se\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2021-01-24T23:00:00+00:00","article_modified_time":"2021-05-26T07:01:55+00:00","og_image":[{"width":945,"height":629,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2183web.jpg","type":"image\/jpeg"}],"author":"marie","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"marie","Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/"},"author":{"name":"marie","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000"},"headline":"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden.","datePublished":"2021-01-24T23:00:00+00:00","dateModified":"2021-05-26T07:01:55+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/"},"wordCount":193,"commentCount":0,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2183web.jpg","articleSection":["Bladder cancer"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/","url":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/","name":"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden. - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2183web.jpg","datePublished":"2021-01-24T23:00:00+00:00","dateModified":"2021-05-26T07:01:55+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2183web.jpg","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/IDL_2183web.jpg","width":945,"height":629},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2021\/01\/25\/idl-biotech-includes-additional-clinics-in-its-ongoing-multicenter-study-for-ubc-rapid-in-sweden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"IDL Biotech includes additional clinics in its ongoing multicenter study for UBC\u00ae Rapid in Sweden."}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/69060a052e2a36c16244e75262d43000","name":"marie","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9710362952388fab63e5da805aba53ffa28210c7bbb0be5447148f193ce03ad4?s=96&d=mm&r=g","caption":"marie"},"url":"https:\/\/idldiagnostics.com\/se\/author\/marie\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=1922"}],"version-history":[{"count":2,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1922\/revisions"}],"predecessor-version":[{"id":2647,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/1922\/revisions\/2647"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/2618"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=1922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=1922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=1922"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=1922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}